Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. has filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt …
Valeant Pharmaceuticals (VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription products. The company was founded in 1983 and is headquartered in Laval, Quebec, …
In a new report on Quebec's Valeant Pharmaceuticals, short-seller Citron Research says the stock is "toxic" and predicts the drug company will soon have difficulty paying its debt as it undergoes investigation. Although Valeant said last …
But just because Munger exaggerates how bad Valeant’s acquisition spree has been doesn’t mean the stock is necessarily a buy at these levels. The company had earnings of just $2.67 per share in 2014, putting the stock at a P/E …
But Valeant stopped short of announcing a new mix of cash and stock, instead saying it was “prepared to improve its offer and provide value to your shareholders of at least $200 a share.” That would be an increase of roughly 20 percent from …
Michael Pearson, former chief executive of Valeant Pharmaceuticals International Inc., is suing the embattled drugmaker for refusing to pay him more than 3 million company shares that he said he is owed. Continue Reading Below In a …
(Reuters) - Activist investor Bill Ackman said Valeant Pharmaceuticals International Inc’s (VRX.N) (VRX.TO) stock was an “extraordinary bargain” given its low price. More doctors could use specialty pharmacies, potentially benefiting Valeant, …
Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's connection with the specialty pharmacy …
FILE - This May 27, 2013, file photo, shows the head office and logo of Valeant Pharmaceuticals in Montreal. Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, Feb. 29, 2016, amid ongoing turmoil over the …
(Reuters) - Valeant Pharmaceuticals International Inc (VRX.TO) will likely offer cash and stock incentives to more key U.S. staff as it aims to avoid mass departures from the heavily scrutinized company, a spokeswoman said on …